These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25484311)

  • 1. Cellular Therapies Clinical Research Roadmap: lessons learned on how to move a cellular therapy into a clinical trial.
    Ouseph S; Tappitake D; Armant M; Wesselschmidt R; Derecho I; Draxler R; Wood D; Centanni JM
    Cytotherapy; 2015 Apr; 17(4):339-43. PubMed ID: 25484311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy.
    El Fiky A; Ibenana L; Anderson R; Hare JM; Khan A; Gee AP; Rooney C; McKenna DH; Gold J; Kelley L; Lundberg MS; Welniak LA; Lindblad R
    Clin Transl Sci; 2021 Nov; 14(6):2099-2110. PubMed ID: 34286927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.
    Reed W; Noga SJ; Gee AP; Rooney CM; Wagner JE; McCullough J; McKenna DH; Whiteside TL; Donnenberg AD; Baker AK; Lindblad RW; Wagner EL; Mondoro TH
    Transfusion; 2009 Apr; 49(4):786-96. PubMed ID: 19170985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The investigator-sponsored IND in clinical trials.
    Haakenson C; Fye CL; Sather MR; Toussaint DJ
    Control Clin Trials; 1987 Jun; 8(2):101-9. PubMed ID: 3608504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of cultured stem cells to human non-healing wounds: GMP facility development in an academic setting and FDA requirements for an IND and human testing.
    Yufit T; Carson P; Falanga V
    Curr Drug Deliv; 2014; 11(5):572-81. PubMed ID: 23517627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accommodating clinical trials and other externally manufactured cellular therapy products: challenges, lessons learned and creative solutions.
    Jackson MR
    Cytotherapy; 2022 Jan; 24(1):37-44. PubMed ID: 34305008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy.
    Wonnacott K; Lavoie D; Fiorentino R; McIntyre M; Huang Y; Hirschfeld S
    Cytotherapy; 2008; 10(3):312-6. PubMed ID: 18418776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good manufacturing practice requirements for the production of tissue vitrification and warming and recovery kits for clinical research.
    Laronda MM; McKinnon KE; Ting AY; Le Fever AV; Zelinski MB; Woodruff TK
    J Assist Reprod Genet; 2017 Feb; 34(2):291-300. PubMed ID: 27900615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal organoids: roadmap to the clinic.
    Kasendra M; Troutt M; Broda T; Bacon WC; Wang TC; Niland JC; Helmrath MA
    Am J Physiol Gastrointest Liver Physiol; 2021 Jul; 321(1):G1-G10. PubMed ID: 33950707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
    Harapanhalli RS
    Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory decision strategy for entry of a novel biological therapeutic with a clinically unmonitorable toxicity into clinical trials: pre-IND meetings and a case example.
    Black LE; Bendele AM; Bendele RA; Zack PM; Hamilton M
    Toxicol Pathol; 1999; 27(1):22-6. PubMed ID: 10367668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current regulatory issues in cell and tissue therapy.
    Burger SR
    Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
    BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IND application.
    Ferkany JW; Williams M
    Curr Protoc Pharmacol; 2008 Sep; Chapter 9():Unit 9.10. PubMed ID: 22294234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good Manufacturing Practice (GMP) Translation of Advanced Cellular Therapeutics: Lessons for the Manufacture of Erythrocytes as Medicinal Products.
    McGowan NWA; Campbell JDM; Mountford JC
    Methods Mol Biol; 2018; 1698():285-292. PubMed ID: 29076098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.
    Lefer DJ; Bolli R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):332-9. PubMed ID: 21821536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory considerations in application of encapsulated cell therapies.
    van Zanten J; de Vos P
    Adv Exp Med Biol; 2010; 670():31-7. PubMed ID: 20384216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.